1. Home
  2. SEPN vs PACK Comparison

SEPN vs PACK Comparison

Compare SEPN & PACK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SEPN
  • PACK
  • Stock Information
  • Founded
  • SEPN 2022
  • PACK 1972
  • Country
  • SEPN United States
  • PACK United States
  • Employees
  • SEPN N/A
  • PACK N/A
  • Industry
  • SEPN
  • PACK Containers/Packaging
  • Sector
  • SEPN
  • PACK Consumer Discretionary
  • Exchange
  • SEPN NYSE
  • PACK Nasdaq
  • Market Cap
  • SEPN 631.0M
  • PACK 590.3M
  • IPO Year
  • SEPN 2024
  • PACK N/A
  • Fundamental
  • Price
  • SEPN $5.90
  • PACK $3.50
  • Analyst Decision
  • SEPN Buy
  • PACK Buy
  • Analyst Count
  • SEPN 4
  • PACK 3
  • Target Price
  • SEPN $33.00
  • PACK $9.50
  • AVG Volume (30 Days)
  • SEPN 257.0K
  • PACK 528.0K
  • Earning Date
  • SEPN 05-15-2025
  • PACK 05-01-2025
  • Dividend Yield
  • SEPN N/A
  • PACK N/A
  • EPS Growth
  • SEPN N/A
  • PACK N/A
  • EPS
  • SEPN N/A
  • PACK N/A
  • Revenue
  • SEPN $1,075,000.00
  • PACK $368,900,000.00
  • Revenue This Year
  • SEPN N/A
  • PACK $9.56
  • Revenue Next Year
  • SEPN N/A
  • PACK $7.51
  • P/E Ratio
  • SEPN N/A
  • PACK N/A
  • Revenue Growth
  • SEPN 611.92
  • PACK 9.69
  • 52 Week Low
  • SEPN $4.17
  • PACK $3.46
  • 52 Week High
  • SEPN $28.99
  • PACK $9.04
  • Technical
  • Relative Strength Index (RSI)
  • SEPN N/A
  • PACK 26.14
  • Support Level
  • SEPN N/A
  • PACK $3.54
  • Resistance Level
  • SEPN N/A
  • PACK $3.88
  • Average True Range (ATR)
  • SEPN 0.00
  • PACK 0.37
  • MACD
  • SEPN 0.00
  • PACK -0.05
  • Stochastic Oscillator
  • SEPN 0.00
  • PACK 4.16

About SEPN SEPTERNA INC

Septerna Inc is a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) oral small molecule drug discovery powered by a proprietary Native Complex Platform. Its industrial-scale platform aims to unlock the full potential of GPCR therapies. The group discovery and development of a pipeline of product candidates focused initially on treating patients in three therapeutic areas: endocrinology, immunology and inflammation, and metabolic disease. Its pipeline includes SEP-786 (PTH1R), SEP-631 (MRGPRX2), TSHR, and GLP-1R, GIPR, GCGR.

About PACK Ranpak Holdings Corp

Ranpak Holdings Corp is a provider of environmentally sustainable, systems-based, product protection solutions for e-Commerce and industrial supply chains. The company offers a full suite of protective packaging systems and paper consumables. Geographically, it derives a majority of revenue from Europe/Asia. They generate revenue by providing its PPS systems and paper consumables to customers, which include direct end-users and our network of exclusive paper packaging solution distributors, and by providing end-of-line automation systems that solve challenges, including optimization, customization, and efficiency.

Share on Social Networks: